Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Analysis of Binimetinib and Palbociclib in RAS-Driven Tumors

NCT04870034 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT04870034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04870034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Analysis of Binimetinib and Palbociclib in RAS-Driven Tumors
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 1
Overall status
Withdrawn
Start date
January 15, 2024
Completion date
September 30, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal carcinoma, lung adenocarcinoma, malignant solid neoplasm, pancreatic carcinoma